LevitasBio, Inc. — Form D
LevitasBio, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-10. The offering totals $25.1M, of which $11.8M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-04-10
- Form: D
- Accession: 0001653494-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $25.1M
- Amount sold: $11.8M
- Remaining: $13.3M
- Investors: 3
- Date of first sale: 2024-03-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-510176
Issuer
- Name: LevitasBio, Inc.
- CIK: 0001713509
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1505 ADAMS DRIVE, Suite D, MENLO PARK, CA, 94025
- Phone: 000-000-0000
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Sandy Gardiner | Director | Menlo Park, CA |
| Greg Herrema | Director | Menlo Park, CA |
| Paul Meister | Director | Waltham, MA |
| Martin Pieprzyk | Director | Menlo Park, CA |
| Steve Tablak | Director | Menlo Park, CA |
| Victor E Tong, Jr. | Director | Menlo Park, CA |
| Martin Pieprzyk | Executive Officer | Menlo Park, CA |
| Xiangmin Cui | Director | Houston, TX |
| Victor Tong | Director | Houston, TX |
| Lars Steinmetz | Director | Menlo Park, CA |
| Zheng E Wang | Director | Menlo Park, CA |
| Utkan Demirci | Director | San Francisco, CA |
Other filings by this issuer (3)
More